Table 3.
Data of pain at pretreatment and post-treatment.
Pretreatment post-treatment intragroup comparison
ES standardized (90% CL) intragroups
Chances
QA
ES standardized (90% CL) between groups
Chances
QA
VAS
Passive
NVFR
-0.5 (-0.91;-0.10)
90/10/0
Likely
0.61 (1.37;-0.15)
82/14/4
Likely
VFR
-1.22 (-1.93;-0.51)
99/1/0
Very likely
Quadriceps isometric activation
NVFR
-0.79 (-1.12;-0.46)
100/0/0
Very likely
0.06 (0.44;-0.31)
27/61/12
Unclear
VFR
-0.6 (-0.79;-0.4)
100/0/0
Very likely
Squat
NVFR
-0.77 (-1.04;-0.51)
100/0/0
Very likely
0.11 (0.59;-0.37)
38/48/14
Unclear
VFR
-0.95 (-1.37;-0.53)
100/0/0
Very likely
Quadriceps Stretching
NVFR
-0.97 (-1.27;-0.66)
100/0/0
Very likely
-0.34 (0.08;-0.75)
71/27/2
Unclear
VFR
-0.73 (-1.07;-0.39)
99/1/0
Very likely
PPT
Lateral vastus
NVFR
0.23(0.05;0.41)
61/39/0
Possibly
0.21 (-0.05;0.46)
51/48/1
Unclear
VFR
0.41 (0.19;0.63)
95/5/0
Very likely
Rectus femoris
NVFR
0.23 (0.07;0.38)
62/38/0
Possibly
0.04 (-0.2;0.28)
14/81/5
Unlikely
VFR
0.35 (0.13;0.56)
87/13/0
Likely
Vastus medialis
NVFR
0.24 (0.03;0.45)
63/37/0
Possibly
0.05 (-0.19;0.29)
14/81/4
Unlikely
VFR
-0.5 (-0.91;-0.10)
90/10/0
Likely
NVFR, non-vibration foam roller group; VFR, vibration foam roller group; VAS, visual analogic scale; PPT, pressure pain threshold; ES, standardized differences; QA, quality assessments.